Home > News > Bioforce Nanosciences receives NIH/NIDDK grant
April 15th, 2003
Bioforce Nanosciences receives NIH/NIDDK grant
BioForce Nanosciences announced today that a $500,000 Phase I NIH/SBIR grant from the National Institute of Diabetes, Digestive, and Kidney Diseases has been awarded to the Company. The award, entitled "Protein Nanoarray for Cytokine Profiling in Mouse Models", aims to build an antibody nanoarray for the creation of diagnostic tests requiring extremely small sample volumes, approaching that of a single cell.
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014